MOESM1 of Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients

MLA

Sylvestre, Aude, et al. MOESM1 of Long-Term Neurocognitive Outcome Is Not Worsened by of the Use of Venovenous ECMO in Severe ARDS Patients. Jan. 2019. EBSCOhost, https://doi.org/10.6084/m9.figshare.8941007.

APA

Sylvestre, A., MÊlanie Adda, FrançOis Maltese, Lannelongue, A., Daviet, F., Parzy, G., Coiffard, B., Roch, A., Loundou, A., Baumstarck, K., & Papazian, L. (2019). MOESM1 of Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients. https://doi.org/10.6084/m9.figshare.8941007

Chicago

Sylvestre, Aude, MĂŠlanie Adda, FrançOis Maltese, Ariane Lannelongue, Florence Daviet, Gabriel Parzy, Benjamin Coiffard, et al. 2019. “MOESM1 of Long-Term Neurocognitive Outcome Is Not Worsened by of the Use of Venovenous ECMO in Severe ARDS Patients,” January. doi:10.6084/m9.figshare.8941007.